Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Set to debut in Europe, the dressing is made from biosynthetic cellulose and designed to reduce downtime and risk after procedures like microneedling and laser therapy.